KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CRISPR Therapeutics AG (CRSP) Goodwill & Intangibles: 2015-2023

Historic Goodwill & Intangibles for CRISPR Therapeutics AG (CRSP) over the last 9 years, with Dec 2023 value amounting to $16,000.

  • CRISPR Therapeutics AG's Goodwill & Intangibles fell 96.49% to $2,000 in Q1 2024 from the same period last year, while for Mar 2024 it was $2,000, marking a year-over-year decrease of 96.49%. This contributed to the annual value of $16,000 for FY2023, which is 77.46% down from last year.
  • Per CRISPR Therapeutics AG's latest filing, its Goodwill & Intangibles stood at $16,000 for FY2023, which was down 77.46% from $71,000 recorded in FY2022.
  • CRISPR Therapeutics AG's 5-year Goodwill & Intangibles high stood at $235,000 for FY2019, and its period low was $16,000 during FY2023.
  • In the last 3 years, CRISPR Therapeutics AG's Goodwill & Intangibles had a median value of $71,000 in 2022 and averaged $70,667.
  • Data for CRISPR Therapeutics AG's Goodwill & Intangibles shows a maximum YoY slumped of 77.46% (in 2023) over the last 5 years.
  • Over the past 5 years, CRISPR Therapeutics AG's Goodwill & Intangibles (Yearly) stood at $235,000 in 2019, then fell by 23.40% to $180,000 in 2020, then crashed by 30.56% to $125,000 in 2021, then tumbled by 43.20% to $71,000 in 2022, then plummeted by 77.46% to $16,000 in 2023.